Copyright Reports & Markets. All rights reserved.

United Kingdom Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

Request for Sample of this report
Buy now

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 7

  • 2.1 What Is This Report About? 7
  • 2.2 Diabetes Care Devices Market Segmentation 7
  • 2.3 Definitions of Markets Covered in the Report 8

3 Diabetes Care Devices Market, United Kingdom 10

  • 3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 10
  • 3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2019 12
  • 3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2019 13
  • 3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2025 14
  • 3.5 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 16
  • 3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2025 18
  • 3.7 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2019 20

4 Glucose Monitoring Market, United Kingdom 22

  • 4.1 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2025 22
    • 4.1.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 24
  • 4.2 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2025 26
    • 4.2.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2025 28
  • 4.3 Glucose Monitoring Market, United Kingdom, Average Price ($) , 2015-2025 30
  • 4.4 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2019 31
  • 4.5 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2019 32

5 Insulin Delivery Market, United Kingdom 33

  • 5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2019 33
  • 5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2019 34
  • 5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2025 35
    • 5.3.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 37
    • 5.3.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 39
  • 5.4 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 41
    • 5.4.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2025 43
    • 5.4.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2025 45
  • 5.5 Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2025 47
  • 5.6 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2019 48
  • 5.7 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2019 49

6 Overview of Key Companies in United Kingdom, Diabetes Care Devices Market 51

  • 6.1 DexCom Inc 51
    • 6.1.1 Company Overview 51
  • 6.2 Medtronic Plc 51
    • 6.2.1 Company Overview 51
  • 6.3 Abbott Laboratories 51
    • 6.3.1 Company Overview 51
  • 6.4 Novo Nordisk AS 52
    • 6.4.1 Company Overview 52
  • 6.5 Sanofi 52
    • 6.5.1 Company Overview 52
  • 6.6 Eli Lilly and Co 52
    • 6.6.1 Company Overview 52
  • 6.7 Ypsomed Holding AG 53
    • 6.7.1 Company Overview 53
  • 6.8 F. Hoffmann-La Roche Ltd 53
    • 6.8.1 Company Overview 53

7 Diabetes Care Devices Market Pipeline Products 54

    8 Financial Deals Landscape 55

    • 8.1 Equity Offerings 55
      • 8.1.1 Midatech Pharma Raises USD3 Million in Private Placement of American Depositary Shares 55
      • 8.1.2 Nemaura Medical to Raise up to USD19.5 Million in Public Offering of Shares 57
    • 8.2 Partnerships 58
      • 8.2.1 LifeScan Enters into Distribution Agreement with Sanvita Medical 58
      • 8.2.2 Diabeloop and ViCentra Enter into Distribution Agreement 59

    9 Recent Developments 60

    • 9.1 Corporate Communications 60
      • 9.1.1 Feb 27, 2020: ConvaTec Group: Non-executive director appointment 60
      • 9.1.2 Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members 60
      • 9.1.3 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 61
      • 9.1.4 Sep 09, 2019: Midatech Pharma announces directorate change 61
      • 9.1.5 Aug 19, 2019: AstraZeneca appoints Michel Demaré to its board of directors 62
      • 9.1.6 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec 63
      • 9.1.7 Jul 31, 2019: Midatech Pharma: Appointment of Non-Executive Director 63
      • 9.1.8 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 64
      • 9.1.9 Jun 25, 2019: ConvaTec Group: Board Change 65
    • 9.2 Financial Announcements 65
      • 9.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019 65
      • 9.2.2 Feb 14, 2020: AstraZeneca: Full-year and Q4 2019 results 66
      • 9.2.3 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019 69
      • 9.2.4 Nov 11, 2019: Nemaura medical reports results and provides business update for the second quarter ended september 30, 2019 70
      • 9.2.5 Oct 24, 2019: AstraZeneca: Year-to-date and Q3 2019 results 70
      • 9.2.6 Sep 30, 2019: Midatech Pharma: Interim results for the six months ended 30 June 2019 74
      • 9.2.7 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 79
      • 9.2.8 Aug 09, 2019: Nemaura Medical reports quarterly results for first quarter ended June 30, 2019 79
      • 9.2.9 Aug 01, 2019: ConvaTec Group first half results 2019 80
      • 9.2.10 Jul 25, 2019: AstraZeneca announces H1 2019 results 87
      • 9.2.11 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update 93
      • 9.2.12 Apr 26, 2019: AstraZeneca: Q1 2019 results 95
      • 9.2.13 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018 97
    • 9.3 Government and Public Interest 98
      • 9.3.1 Nov 28, 2019: Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the national reimbursement drug list in China 98
      • 9.3.2 May 21, 2019: DiaMedica Therapeutics announces formation of scientific advisory board for kidney disease 100
    • 9.4 Legal And Regulatory 102
      • 9.4.1 Nov 12, 2019: OGT continues move into molecular diagnostics markets 102
      • 9.4.2 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition 102
    • 9.5 Other Significant Developments 103
      • 9.5.1 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 103
      • 9.5.2 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 103
      • 9.5.3 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 103
      • 9.5.4 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 104
      • 9.5.5 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business 104
    • 9.6 Product News 104
      • 9.6.1 Jan 13, 2020: Artificial Intelligence (AI) can detect low-glucose levels via ECG without fingerpick test 104
    • 9.7 Strategy And Business Planning 105
      • 9.7.1 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition 105
      • 9.7.2 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 106
      • 9.7.3 Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination 107

    10 Appendix 108

    • 10.1 Research Methodology 109
      • 10.1.1 Coverage 109
      • 10.1.2 Secondary Research 109
      • 10.1.3 Primary Research 110
      • 10.1.4 Market Modeling and Forecasting 110
      • 10.1.5 Company Share Analysis 112
      • 10.1.6 Distribution Share Analysis 112
      • 10.1.7 Benchmarking 113
    • 10.2 GlobalData Consulting 113
    • 10.3 Contact Us 114

    United Kingdom Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

    Summary

    GlobalData’s “United Kingdom Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Glucose Monitoring and Insulin Delivery.

    The United Kingdom Diabetes Care Devices Market report provides key information and data on -
    - Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
    - 2019 company share and distribution share data for Diabetes Care Devices Market.
    - Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

    Scope

    United Kingdom Diabetes Care Devices is segmented as follows -
    - Glucose Monitoring and Insulin Delivery

    Reasons to Buy

    The United Kingdom Diabetes Care Devices Market report helps you to develop -
    - Business strategies by identifying the key market segments poised for strong growth in the future.
    - Market-entry and market expansion strategies.
    - Design competition strategies by identifying who-stands-where in the market.
    - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
    - Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
    Buy now